TABLE 2.
Cox regression analysis using PFI as a prognostic category.
| Characteristics | Total(N) | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|---|
| Hazard ratio (95% CI) | P value | Hazard ratio (95% CI) | P value | ||
| TRIM2 | 501 | ||||
| Low | 250 | Reference | Reference | ||
| High | 251 | 0.620 (0.409–0.940) | 0.024 | 0.603 (0.364–0.999) | 0.0496 |
| Pathologic T stage | 494 | ||||
| T2 | 189 | Reference | Reference | ||
| T3&T4 | 305 | 3.745 (2.118–6.623) | 5.64e-06 | 1.775 (0.840–3.749) | 0.1326 |
| Clinical T stage | 407 | ||||
| T1&T2 | 352 | Reference | Reference | ||
| T3&T4 | 55 | 3.799 (2.357–6.123) | 4.27e-08 | 1.995 (1.157–3.438) | 0.0129 |
| Pathologic N stage | 428 | ||||
| N0 | 348 | Reference | Reference | ||
| N1 | 80 | 1.901 (1.175–3.078) | 0.0089 | 1.227 (0.698–2.156) | 0.4766 |
| Clinical M stage | 460 | ||||
| M0 | 457 | Reference | |||
| M1 | 3 | 3.587 (0.497–25.906) | 0.2055 | ||
| Gleason score | 501 | ||||
| 6 | 46 | Reference | Reference | ||
| 7 | 248 | 4.362 (0.590–32.245) | 0.149 | 18,097,592.9195 (0.000 - inf) | 0.996 |
| 8and9and10 | 207 | 17.934 (2.490–129.154) | 0.0042 | 49128701.1623 (0.000 - inf) | 0.996 |
| PSA (ng/mL) | 444 | ||||
| <4 | 417 | Reference | Reference | ||
| ≥ 4 | 27 | 4.223 (2.108–8.459) | 4.82e-05 | 2.530 (1.097–5.837) | 0.0295 |
| Age | 501 | ||||
| ≤ 60 | 225 | Reference | |||
| >60 | 276 | 1.304 (0.865–1.967) | 0.205 | ||
Bolded values indicate statistical significance.